Wellington Management Group’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-227,229
Closed -$2.05M 2014
2025
Q4
$2.05M Buy
+227,229
New +$1.7M ﹤0.01% 1595
2023
Q4
Sell
-1,342,977
Closed -$46.6M 1933
2023
Q3
$46.6M Sell
1,342,977
-6,655
-0.5% -$230K 0.01% 710
2023
Q2
$44.3M Buy
1,349,632
+479,127
+55% +$16.5M 0.01% 736
2023
Q1
$29.2M Buy
870,505
+260,232
+43% +$10.1M 0.01% 833
2022
Q4
$20M Sell
610,273
-187,172
-23% -$5.54M ﹤0.01% 916
2022
Q3
$27.8M Sell
797,445
-100,176
-11% -$2.22M 0.01% 823
2022
Q2
$11M Sell
897,621
-605,350
-40% -$9.05M ﹤0.01% 1102
2022
Q1
$20.3M Sell
1,502,971
-325,557
-18% -$4.35M ﹤0.01% 1011
2021
Q4
$35.7M Buy
+1,828,528
New +$34.7M 0.01% 942

Other funds holding VTYX

Wellington Management Group's VTYX Position: Q1 2026 in Review

Wellington Management Group sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 227,229 shares — an estimated $2.05M sold.

Wellington Management Group first reported a position in VTYX in Q4 2021 and held it in 9 quarters. The position peaked at $46.6M in Q3 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Wellington Management Group reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Wellington Management Group sold 227,229 Ventyx Biosciences shares in Q1 2026, an estimated $2.05M.
  • Wellington Management Group first reported a position in Ventyx Biosciences in Q4 2021 and held it in 9 quarters.
  • Wellington Management Group's Ventyx Biosciences position peaked at $46.6M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.